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The discovery of T-cell (thymus derived) and B-cell (bone marrow derived)
cooperation in the immune response (1-3) and the subsequent finding that
either or both cells may be involved in immunologic tolerance (4, 5) has been
critical to our understanding of both cellular immunology and tolerance . For
example, split (6) or partial tolerance (7) is now understood as T-cell tolerance
with B-cell immunity. Moreover, the T cell has been shown to play an increasing
role in establishing and maintaining B-cell tolerance (8) to a number of anti-
gens. Although experiments in vitro indicate that T cells are tolerant to self
antigens (9) and it is known that either T or B cell need to be tolerant to a
heterologous antigen for the intact animal to be unresponsive (10), it is not clear
whether both cells are involved in tolerance to autologous antigen. To approach
this question we have used one system of carrier-determined tolerance which
closely resembles "self" tolerance (11, 12). Animals were made tolerant to a
hapten conjugated to isologous gamma globulin and immunized with the identi-
cal hapten conjugated to heterologous carrier protein. Relatively pure popula-
tions of T and B cells from either normal or tolerant mouse spleen cells were
obtained. The immune response of mixtures of either tolerant T and normal B
cells, or conversely, normal T and tolerant B cells was examined in lethally
irradiated isogeneic recipients. It was found that carrier-determined tolerance
involves both T and B cells.
Materials and Methods
Animals. 3-8-week-old male BDF, mice were purchased from Jackson Laboratories, Bar
Harbor, Maine.
Preparation of Tolerogen .
￿
IgGl (MOPC 245) was isolated from the serum of plasmocytoma-
bearing mice by starch block electrophoresis. Twice recrystallized 2,4-dinitrobenzene sulfonic acid
sodium salt (Eastman Kodak Co., Rochester, N. Y.) was bound to purified myeloma protein as
previously described (11). The subscripts refer to the degree o£ substitution of the hapten carrier
conjugate. The following preparations were used : DNP,2-yl and DNP, ;yl .
Preparation ofAntigen .
￿
Keyhole limpet haemocyanin (KLH)' waspurchased from Pacific Bio
* These studies were supported by the National Institutes of Health and the National Cancer
Institute Contract No. NO1-CB-43970 andby National Institutes of Health grant no. AI-12069 and
Al-11980 and USPHS CA 05167.
'Abbreviations used in this paper: CFA, complete Freund's adjuvant; FCS, fecal calf serum,
HRBC, horse redblood cells ; KLH, keyhole limpet haemocyanin; PBS, phosphate-buffered saline ;
PFC, plaque-forming cells .
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Marine Supply Co., Venice, Calif. DNP44-KLH was prepared as previously described (11) .
Preparation of Cellular Immunoabsorbant.
￿
Mouse Fab was prepared from a pepsin digest of
mouse Ig, emulsified in complete Freund's adjuvant, and used to immunize rabbits for the
production of antimouse Fab. The resulting antisera were purified over Sepharose 4B mouse-Ig
immunoabsorbant columns, concentrated, dialyzed, and stored at -20°C . The purified antibody
was conjugated to cyanogen bromide-activated Sephadex G-200 (Pharmacia Fine Chemicals, Inc.,
Piscataway, N. J.) by methods previously described (13). Approximately 0.3 mg of antibody was
routinely bound/ml of activated Sephadex. 12-ml disposable syringes are fitted with polyethylene
disks (Bel-Art Products, Pequannock, N. J.) andpacked with 12-15 ml of the Sephadex conjugate.
The columns were washed with Liebowitz-15 (Microbiological Associates, Bethesda, Md.) contain-
ing 5% fetal calf sera (FCS), 2.5 mM EDTA, 50 U/ml penicillin-streptomycin solution, incubated at
37°C for 60 min, and returned to 4°C for cell fractionation.
Cell Preparation and Cell Fractionation.
￿
250-300 x 106 mouse spleen cells from either normal
or tolerant animals were teased into the above media without EDTA, aggregates sedimented, cells
washed three times, andthe resulting single cell suspension treated with iron carbonyl at 37°C for
30 min. The phagocytic cells were removed in a magnetic field. Cells were resuspended in EDTA
containing mediaand placed on the 12-15-ml column in aconcentration of approximately 30 x 106
cells/ml. The cells were applied to the column at 4°C andcollected by stepwise elution with 15-ml
aliquots of EDTA-containing medium. To recover the adherent cells competitive absorption was
carried out using medium with 10% autologous mouse sera as a source of gamma globulin (14) .
Usually 90-100% of the total cells were recovered. Cells viability, as determined by trypan blue
exclusion test, before and after cells fractionation was 90-95%.
Analysis ofSurface Characteristics.
￿
Unfractionated, nonretained, andserum-eluted cell popu-
lations were studied with respect to surface Ig properties. The presence of surface Ig wasdetected
by using a direct fluoresceinated antibody technique. To approximately 2 x 106 cells was added 0.1
ml of fluoresceinated rabbit antimouse Fab and the reaction mixture incubated at 4°C for 30 min.
The cells were then washed three times with cold phosphate-buffered saline (PBS) containing 10%
FCS, suspended in a glycerol-PBS buffer, andviewed with a Zeiss Universal fluorescence micro-
scope (Carl Zeiss, Inc., New York) with an Osram 100 watt ultraviolet light source andwith phase
contrast. Routinely 200 viable cells were counted on the phase contrast and percentage staining
with fluoresceinated rabbit gamma globulin was used. In these experiments, fluoresceinated
normal rabbit IgG stained less than 2% of the cells.
Hemolytic PlaqueAssay.
￿
Compound J-(N-2,4 dinitrophenyl alanyl glycylglycine Boc hydrazide
(purchased from Regis Chemical Co., Morton Grove, Ill.) was covalently bound to sheep red blood
cells (SRBC, Colorado Serum Co., Denver, Colo.) as described by Inman et al. (15). These target
cells were used in the direct hemolytic plaque assay as previously described (11). In some
instances, horse red blood cells (HRBC, Colorado Serum Co.) were used in the Jerne hemolytic
plaque assay.
Statistical Analysis.
￿
Statistical analysis was done according to the Student's t test. For the
PFC/spleen, the geometric mean of each group wascalculated.
Results
Transfer of Tolerance with Spleen Cells. Preliminary experiments were
done to determine whether spleen cells obtained from tolerant animals could
transfer tolerance to lethally irradiated recipient mice . Two treatment sched-
ules were used for tolerance induction. 6-wk-old BDF, mice were injected with a
single i.v. dose (0.2 mg or 1 mg) of DNP,S-yl; 3-wk-old BDF, mice were treated
weekly with 0.2 mg of DNP,s-yl i.v. for 4 wk. 1 wk after the last injection of
tolerogen spleen cell suspension from tolerant animals were used to repopulate
lethally irradiated (960 rad) recipient animals. Normal spleen cells from age-
matched controls were also used. Immediately after reconstitution, they were
immunized i.p. with 1 mg of DNP-KLH in complete Freund's adjuvant (CFA).
The number of antibody-forming cells to DNP was determined 8 days later. As
seen in Table I, the ability to transfer tolerance with spleen cells of animals125 6 T AND B CELL IN HAPTEN-SPECIFIC CARRIER-DETERMINED TOLERANCE
TABLE I
Transfer of Tolerance to DNP by Spleen Cells from Animals Made Tolerant for 1 Wk
given a single injection of tolerogen 1 wk previously was dose dependent.
Although animals injected i.v. with 0.2 mg ofDNP, yl are themselves tolerant,
theirspleen cellsfail to transfer toleranceto irradiated hosts. In contrast, spleen
cells from donor animals injected with 1 mg of DNP,,-yl exhibit a significantly
(P > 0.001) lower number of DNP antibody-forming cells than normal spleen
cells after adoptive transfer to lethally irradiated recipients. Similarly, the
spleen cells of animals treated weekly with 0.2 mg of DNP,,-yl for 1 mo
remained tolerant in irradiated recipient animals.
Transfer of Tolerance with T and B Cells
DONOR ANIMALS TOLERANT FOR 4 WK.
￿
Spleen cells of animals tolerant for 1
mo were initially used to study the cellular basis oftolerance. Aweek after the
last tolerogen injection, the spleen cell suspensions from these tolerant ani-
mals were fractionated on the cellular immunoabsorbant column to obtain
pure samples ofT (nonimmunoglobulin-bearing cells) and B (immunoglobulin-
bearing) cells to be referred to as tolerant T and tolerant B cells. Similarly,
spleen cell suspensions of untreated 7-wk-old BDF, mice were fractionated on
another cellular absorbant column to obtain normal T and B cells. A mixture of
tolerant T and normal B cells, orconversely, normal T cells and tolerant B cells
was used to repopulate lethally irradiated (960 rad) isogenic 8-wk-old BDF,
mice. The total number ofcells used to restore one irradiated host was 20 x 106
and the T/B ratio 1/1 with the exception of one instance where 40 x 106 cells
were transferred with a T/B ratio of 3/1. Immediately after cell transfer, the
recipient animals were immunized with 1 mg ofDNP-KLH given i.p. in CFA.
8 days later, the direct hemolytic plaque assay was done. The results (Table II)
show that as expected, the whole spleen cells population readily transferred
tolerance.
Also, tolerance can be readily transferred with a mixture of tolerant B cells
and normal T cells in a ratio of 1/1 corresponding to that found in the whole
spleen. On the other hand, when the ratio oftolerant T cells and normal B cells
was 1/1, no diminution ofthe immune response was observed. However, at a 3/1
ratioit was diminished. This suggests thata T/B ratio in excess ofthe one found
in the spleen is required to demonstrate T-cell tolerance.
This question was examined in the next series of experiments in which the
Donor treatment
Spleen cells trans-
ferred
No. irradi-
ated BDF, re-
cipient mice
DNP-PFC/S (±SE)
None 40 x 106 6 49,101 (8,044)
0.2 mg DNP,Syl 40 x 101 6 42,192 (4,824)
None 40 x 106 6 44,404 (7,613)
1 mg DNP,5-Y' 40 x 106 6 8,392 (1,419)
None 40 x 106 6 47,504 (4,034)
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hapten specificity of T-cell tolerance was sought. Lethally irradiated BDF, mice
were repopulated with T cells from 4-wk tolerant mice and normal B cells. 25 x
106 cells were transferred, and the TB ratio was 4/1 . As a control, mice were
repopulated with normal T and B cells in the same ratio. Animals of both groups
were immunized with 1 mg o£ DNP-KLH given i .p. in CFA and 0.2 ml of 20% of
HRBC . 8 days later, the direct hemolytic plaque assay to both antigens was
done. The results show (Table 111) that animals repopulated with tolerant T cells
and normal B cells in a ratio of 4/1 are tolerant as compared to controls
repopulated with the same ratio of normal T and normal B cells. Perhaps of
greater importance, T cell tolerance was hapten specific. It is not clear why
animals repopulated with fractionated populations ofT and B cells have a lower
response to HRBC than animals repopulated with the whole spleen cell popula-
tion in which the transfer of tolerance was also hapten specific.
TABLE II
Donor Animals Tolerant for 4 Wk
* N. T., normal T cell; Tol. T, tolerant Tcell ; Tol. B; tolerant B cell ; N. B; normal B cell ; N. Spl.,
normal spleen ; Tol. Spl., tolerant spleen.
TABLE III
Donor Animals Tolerant for 4 Wk
* N. Spl., normal spleen cells; Tol. Spl., tolerant spleen cells; N. T; normal Tcell; N. B, normal B
cell ; Tol. T, tolerant T cell.
No. irradi-
ated BDF,
recipient
mice
T/B ra-
do
Restoring cells DNP-
PFC/S (±SE) P
HRBC-
PFC/S (±SE)
6 25 x 106 N. Spl.* 10,175 (1,638) 18,285 (3,465)
5 25 x 106 Tol. Spl. 3,412 (799) <0.005 14,805 (3,795)
5 4/1 20 x 106 N. T 11,408 (4,418) 4,699 (4,521)
5x101 N.B
5 4/1 20 x 106 Tol. T 1,328 (520) <0.005 3,189 (1,157)
5x106 N.B
No. irradi-
atedBDF, re-
cipient mice
T/B ratio Restoring cells DNP-PFC/S (-SE) P
9 20 x 106 N. Spl .* 19,159 (2,151)
8 20 x 106 Tol. Spl. 2,556 (967) <0.001
10 1/1 10 x 106 N. T 3,319 (515) <0.001
10 x 106 Tol. B
10 1/1 10 x 106 Tol. T 10,220 (3,788) >0.05
10 x 106 N. B
4 3/1 30 x 106 Tol . T 10,559 (1,553) <0.025
10 x 106 N. B1258 T AND B CELL IN HAPTEN-SPECIFIC CARRIER-DETERMINED TOLERANCE
To determine whether tolerance was also hapten specific at the B cell level, a
similar experiment was done in which animals were repopulated with normal T
cell and tolerant B cells in a 1/1 ratio. Table IV shows that while the number of
anti-DNP PFC was depressed, the response to HRBC was the same as in the
controls. Thus, carrier-determined tolerance is hapten specific for both T and B
cells.
DONOR ANIMALS TOLERANT FOR 1 WK.
￿
The next series of experiments were
designed to determine whether both T and B cells were tolerant in animals
tolerant for 1 wk. Spleen cells of animals injected with a single injection of 1 mg
of DNP,,-yl i.v. 1 wk before were fractionated to obtain populations of T and B
cells from tolerant animals (tolerant T andtolerant B cells). Similarly, T- and B-
cell suspensions were obtained from 7-wk-old BDF, mice . As before, mixtures of
tolerant T cells and normal B cells, or conversely, normal T cells and tolerant B
cells were used to repopulate lethally irradiated mice. Each recipient animal
received 25 x 106 cells. The T/B ratio was 4/1. Immediately after cell transfer,
recipient animals were immunized with 1 mg of DNP-KLH given i.p. in CFA. 8
days later, the direct hemolytic plaque assay was done. The results of three
separate experiments were summarized in Table V. Tolerance is transferred
with the whole spleen population and similarly at a 4/1 ratio with a mixture of
tolerant T cells and normal B cells. On the other hand, 20 x 106 normal T cell
TABLE IV
Donor Animals Tolerant for 4 Wk
* See footnotes Table II and III.
TABLE V
Donor Animals Tolerant for 1 Wk
5 x 106 Tol. B
* See footnotes Table 11 and III .
No. irradi-
ated BDF, re-
cipient mice
T/B ratio Restoring cells DNP-PFC/S (±SE) P
13 25 x 106 N. Spl.* 15,063 (2,292)
10 25 x 106 Tol. Spl . 6,952 (1,560) <0.01
13 4/1 20 x 106 Tol. T 6,956 (1,781) <0.025
5x101 N.B
15 4/1 20 x 106 N. T 17,114 (2,636) >0 .5
No. irradi-
atedBDF, re-
cipient mice
T/B ratio Restoring cells DNP-PFC/S (±SE)
HRBC-
PFC/S
(±SE)
4 20 x 106 N. Spl.* 15,960 (2,841) 7,459 (2,058)
3 20 x 106 Tol. Spl. 1,773 (1,358) 7,195 (2,282)
5 1/1 10 x 106 N. T 4,407 (948) 8,195 (951)
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and 5 x 106 tolerant B cell fails to transfer tolerance. These results suggest that
tolerance was only observed in the T-cell population . To resolve this question,
the experiment was repeated but the ratio of tolerant B cells and normal T cells
was 1/1, corresponding to the one found in the spleen. Under these conditions,
tolerance could be shown in the B-cell population as well (Table VI). Why it
was not demonstrated with 5 x 106-tolerant B cells in the previous experi-
ments is not clear. Again, as shown above (Table V) at a 4/1 ratio, T cells also
transfer tolerance .
Discussion
The data described above indicates that hapten-specific carrier-determined
tolerance affects the T- and B-cell populations. The observation that both cell
types are involved, has several implications: First, it confirms that both T cells
and B cells are the target of tolerance induction to a protein antigen (4), as well
as to a hapten linked to isologous protein (16) . Secondly, it shows that hapten-
specific carrier-determined tolerance is not necessarily only an example of B-cell
tolerance. Lastly, it raises questions concerning the cellular recognition by T
cells of a hapten bound to a "self' carrier and how tolerant T cells influence
normal B cells.
Others have shown that a hapten linked to T-independent antigens induces 13-
cell tolerance (17-20) even in nude mice which are presumably without T cell
(21). However, it is not known when T cells were present whether they were also
tolerant. Our results clearly show that a hapten-specific tolerant T cell prevents
a normal B cell from forming antihapten antibody. Why more tolerant T cells
are needed than tolerant B cells to demonstrate tolerance is unclear. In our
system, DNP isologous gamma globulin can be considered analogous to a T-
independent antigen since we presume that no carrier cell exists for "self' IgG.
However, the possibility that T cells recognize self antigen cannot be ruled out,
and, in fact, the data show that DNP isologous IgG is recognized by T cells.
Moreover, in a system analogous to our model, it was shown that mice made
tolerant to the hapten NIP conjugated to mouse gamma globulin (NIP-MGG) do
not respond to NIP-MGG in vitro (22). The authors conclude that tolerance
TABLE VI
Donor Animals Tolerant for 1 Wk
* See footnotes Tables II and III.
No. irradi-
atedBDF, re-
cipient mice
T/B ratio Restoring cells DNP-PFC/S (±SE) P
5 25 x 106 N. Spl.* 26,028 (3,694)
5 25 x 106 Tol. Spl. 9,596 (2,256) 0.01
5 4/1 20 x 106 Tol. T 4,739 (822) 0.001
5x101 N.B
5 1/1 10 x 106 N. T 3,069 (1,617) 0 .001
10 x 106 Tol. B1260 T AND B CELL IN HAPTEN-SPECIFIC CARRIER-DETERMINED TOLERANCE
induced by NIP-MGG involves not only B cells but also T cells, again implying
that a hapten autologous carrier is recognized by T cells and that such cells can
be rendered tolerant. It is worth mentioning that the ability to render the T cell
tolerant in carrier-determined tolerance mightbe important for the therapeutic
application of this experimental model. For example, in allograft transplanta-
tion and in prevention of autoimmune disease (23) T-cell tolerance might be
critical .
It is conceivable that T-independent antigens are only independent as far as
the helper T cell, but T-dependent as far as suppressor T cells are concerned.
Perhaps, T-independent antigens are T-dependent tolerogen. If this is the case,
the predominant 19S antibody response provoked by T-independent antigen
would represent an example of partial tolerance since it is known that T cells are
required to make IgG antibody, and T cells are more susceptible to tolerance
induction than B cells.
Finally, one critical question that cannot be answered by these results is how
T and B cells are made tolerant. While B-cell tolerance can be readily explained,
for example, by receptor blockade, (24) how tolerant T cells turn off normal B
cells is unknown. At least two possibilities that are not mutually exclusive can
be offered. We are dealing with either a specific tolerant T cell and/or a hapten-
specific suppressor T cell . There is no evidence to support the latter . The former
is consistent with our recent finding that the receptor of the antigen-binding cell
is specifically blocked by the tolerogen (24) . Thus, receptor blockade on T cell by
DNP-isologous IgG would prevent the cooperative effect of DNP-KLH . The
recent observation that DNP-mouse gamma globulin raises hapten-specific
helper T cell is consistent with this interpretation. (25) Alternatively, after a T-
cell receptor blockade, a T-cell product (which might be the tolerogen itself)
might suppress the B cell. The view of a T-cell product to suppress B cells is
consistent with requirement of a relatively large number of tolerant T cells
turning off normal B cells upon transfer to irradiated hosts. An attractive
possibility would be that a suppressor T cell is a T cell with its receptor occupied
by the tolerogen. Further studies are in progress to determine the cellular origin
of the tolerant cell. In any event, our results clearly show that B cell antibody
production failed in the presence of a hapten-specific tolerant T cell. Whether
this results from active suppression or lack of help cannot be determined from
the above data .
Summary
BDF, mice were made tolerant by a single i .v. injection of 1 mg of DNP-yl or
by weekly i.v. injections of 0 .2 mg of DNP-yl given for a month. In both
instances, spleen cells of tolerant animals were fractionated to obtain pure
populations ofT cells (nonimmunoglobulin-bearing cells), referred to as tolerant
T cells, and B cells (immunoglobulin-bearing cells) referred to as tolerant B
cells. The control cells were similarly fractionated to obtain normal T and B
cells. Mixtures of tolerant T cells and normal B cells, or conversely, normal T
cells and tolerant B cells were used to repopulate lethally irradiated recipients.
These recipients were then immunized with dinitrophenyl-keyhole limpet hae-
mocyanin and in certain instances with other antigen horse red blood cells. TheYVES BOREL, CAROL L. REINISCH, AND STUART F. SCHLOSSMAN
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immune response to both antigens was measured using the direct hemolytic
plaque assay.
It was found that both T and B cells were tolerant and that tolerance was
hapten specific at both T- and B-cell levels. While B-cell tolerance was demon-
strated at a 1/1 T/B ratio, a 4/1 T/B ratio was necessary to show T-cell tolerance .
Thus, the hapten-specific carrier-determined tolerance involves not only B cells
but also T cells. The implication of this finding for the cellular mechanism of
tolerance in an experimental model closely related to selftolerance is discussed.
The expert technical assistance of Ms. Nancy Gleiner and Ms. Lynne Kilham was greatly
appreciated.
Received for publication 23 June 1975.
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